Table 2.

Logistic-regression analysis by HT category and functional outcome.

Variables	Univariate			Multivariate
	OR	95% CI	P-value	OR	95% CI	P-value
PH vs. NO PH
Atrial fibrillation	1.39	0.55–3.51	0.480	–
Hypertension	0.75	0.31–1.85	0.535	–
Diabetes	0.88	0.28–2.71	0.821	–
Hyperlipidemia	0.51	0.19–1.35	0.177*	0.48	0.14–1.63	0.241
Aspirin use	1.47	0.55–3.97	0.444	–
Age, year	1.01	0.98–1.04	0.418	–
NIHSS	1.04	0.98–1.10	0.222	–
Glucose, mg/dL	1.01	1.00–1.02	0.145*	1.01	1.00–1.02	0.065
Time to treatment, h	1.04	0.98–1.11	0.198*	1.05	0.95–1.16	0.378
Post-treatment TIMI	1.48	0.90–2.45	0.121*	1.22	0.62–2.40	0.568
ADC-thresholded volume	1.24	1.03–1.49	0.025*	0.68	0.42–1.10	0.115
ASL reperfusion vol-25	2.07	1.45–2.96	0.001**	3.39	1.61–7.17	0.001**
IV thrombolysis	1.35	0.40–4.55	0.624	–
IA thrombolysis	0.53	0.11–2.60	0.431	–
Clot retrieval	1.88	0.78–4.57	0.161*	0.93	0.30–2.83	0.896
Qualitative hyperperfusion	1.01	0.43–2.40	0.976	–
Relative reperfusion volume	1.39	0.35–5.56	0.646	–
PH-2 vs. NO PH-2
Atrial fibrillation	1.08	0.30–3.81	0.908	–
Hypertension	0.77	0.23–2.57	0.675	–
Diabetes	0.77	0.16–3.80	0.748	–
Hyperlipidemia	1.77	0.55–5.75	0.340	–
Aspirin use	1.64	0.45–5.90	0.451	–
Age, year	1.02	0.97–1.06	0.492	–
NIHSS	1.07	0.99–1.17	0.086*	1.05	0.95–1.17	0.351
Glucose, mg/dL	1.01	0.99–1.02	0.243	–
Time to treatment, h	0.92	0.76–1.12	0.396	–
Post-treatment TIMI	1.48	0.73–3.00	0.272	–
ADC-thresholded volume	1.35	1.06–1.71	0.014*	0.89	0.54–1.47	0.649
ASL reperfusion vol-25	2.18	1.42–3.37	0.001**	2.32	1.13–4.76	0.022†
IV thrombolysis	0.62	0.15–2.55	0.510	–
IA thrombolysis	1.62	0.31–8.47	0.570	–
Clot retrieval	3.67	1.10–12.3	0.034*	2.33	0.58–9.32	0.233
Qualitative hyperperfusion	0.92	0.29–2.95	0.884	–
Relative reperfusion volume	0.71	0.11–4.47	0.714	–

^*P < 0.2 (inclusion in multiple logistic regression);

^**P < 0.003125 (significance after Bonferroni correction);

^†P < 0.05.